AR	androgen receptor
ATT	androgen-targeted therapies
BCR	biochemical recurrence
CSC	cancer stem cells
CRPCa	castration resistant prostate cancer
CT	chemotherapy
DCs	dendritic cells
DHT	dihydrotestosterone
EGF	epidermal growth factor
ENZ	enzalutamide
EGFR	epidermal growth factor receptor
HGF	hepatocyte growth factor
HUVEC	human endothelial cells
IGF1-R	insulin-like growth factor 1 receptor
IR	ionizing radiation
IHC	immunohistochemistry
mAbs	monoclonal antibodies
mCPRC	metastatic castration-resistant prostate cancer
miRs	microRNAs
NRPs	Neuropilins
NRP1	Neuropilin-1
NRP2	Neuropilin-2
NSCLC	non-small cell lung cancer
sNRPs	soluble neuropilins
OS	overall survival
PDACs	pancreatic ductal adenocarcinomas
PDGF	platelet derived growth factor
PDGF-Rs	platelet-derived growth factor receptors
PCa	prostate cancer
RCT	radio-chemotherapy
RT	radiotherapy
SEMAs	semaphorins
TGFβ	transforming growth factor β
TURBT	transurethral resection of bladder tumour
TAMs	tumor-associated macrophages
RTKs	tyrosine kinase receptors
VEGF	vascular endothelial growth factor
VEGF-Rs	vascular endothelial growth factor receptors